Heart Disease News and Research

Latest Heart Disease News and Research

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Companion diagnostics is critical in helping to pave the way for personalized medicine, in which the treatment is adapted and precisely tailored to the patient.

From Siemens Healthineers 27 Aug 2013

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt has added genetic screening for the drug tacrolimus to its personalize medicine pharmacogenomics program PREDICT. The new drug screening protocol was added following data that shows a single genetic variation largely impacts different dose requirements for patients.

27 Aug 2013

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

27 Aug 2013

Intracerebral injection of BSC may reduce post-stroke cognitive dysfunction

27 Aug 2013

Wait times for colorectal cancer procedures at VA hospitals increase to 32 days

A study published in the August print issue of the Journal of Oncology Practice shows that from 1998-2008, wait times for colorectal cancer operations at Veterans Administration hospitals increased from 19 to 32 days. But researchers think longer waits may be a reflection of several unmeasured variables including more careful care, staffing, and patient conditions or preferences.

27 Aug 2013

Unique computer technology opens up discovery of smarter drugs to treat illnesses

A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

BSCs may offer new approach for reducing post-stroke cognitive dysfunction

Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.

26 Aug 2013

Levels of mercury in Pacific Ocean fish likely to increase in coming decades

University of Michigan researchers and their University of Hawaii colleagues say they've solved the longstanding mystery of how mercury gets into open-ocean fish, and their findings suggest that levels of the toxin in Pacific Ocean fish will likely rise in coming decades.

26 Aug 2013

Researchers discover link between epilepsy drug and risk of having baby with birth defects

In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.

26 Aug 2013

Athera Transfers Annexin A5 Project To Medirista

...

23 Aug 2013

AVERT System receives FDA clearance for controlled infusion of radiopaque contrast media in angiographic procedures

Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.

23 Aug 2013

Athera Transfers Annexin A5 Project To Medirista

...

23 Aug 2013

Researchers request all countries to record smoking on death registries

Researchers today [Friday 23 August] call for official death registries in all countries to record whether the dead person was a smoker, in a research Article published in The Lancet.

23 Aug 2013

Millions of Chinese face risk of chronic arsenic poisoning

Since the 1960s, it has been known that groundwater resources in certain provinces of China are contaminated with arsenic. Estimates of the numbers of affected people have risen year by year. In the most recent survey - conducted by the Chinese Ministry of Health between 2001 and 2005 - more than 20,000 (5%) of the 445,000 wells tested showed arsenic concentrations higher than 50 -g/L.

23 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Research findings lay foundation for regenerating damaged heart muscle

In the aftermath of a heart attack, cells within the region most affected shut down. They stop beating. And they become entombed in scar tissue. But now, scientists at the Gladstone Institutes have demonstrated that this damage need not be permanent-by finding a way to transform the class of cells that form human scar tissue into those that closely resemble beating heart cells.

23 Aug 2013

Challenges of studying health and mortality risks of obesity

Researchers from the Perelman School of Medicine point out that the body mass index, based on the weight and height, is not an accurate measure of body fat content and does not account for critical factors that contribute to health or mortality, such as fat distribution, proportion of muscle to fat, and the sex and racial differences in body composition.

23 Aug 2013

Healthy and obese kids who participated in lifestyle modification program show improved heart health

A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.

23 Aug 2013

New technique may convert cells from heart disease patients into heart muscle cells

Researchers have developed a new technique that might one day be used to convert cells from heart disease patients into heart muscle cells that could act as a personalized treatment for their condition.

23 Aug 2013